BACKGROUND: The randomized controlled trial (RCT) is the least biased measure of the effectiveness of interventions, including surgical interventions. The aim was to review the available evidence base in gynaecologic surgery, to assess what progress has been made and to determine gaps in the evidence for clinical decision-making. METHODS: Systematic reviews involving gynaecological surgery interventions were extracted from the Cochrane Database of Systematic Reviews (Issue 2, 2007) and data were extracted for key primary outcomes from each of the randomized trials in the reviews. The reviews were categorized as to whether they had provided evidence of effectiveness for pre-defined outcomes of most relevance to patients. RESULTS: Of 371 reviews or protocols published on the Cochrane Database of Systematic Reviews (Issue 2, 2007), only 30 were completed reviews assessing surgical interventions. Seven reviews concluded there was evidence of a significant effect (whether beneficial or harmful) of the interventions studied for pre-defined primary outcomes; 11 reviews concluded there was some evidence of significant effects for primary outcomes along with some gaps for primary outcomes; 12 reviews concluded insufficient evidence of effectiveness. Common themes of unique methodological challenges and pitfalls with trials of surgical interventions were apparent. CONCLUSIONS: Cochrane reviews have gone a long way to establishing a sound evidence base in gynaecologic surgery: some gaps in the evidence have been eliminated and others highlighted. In general, gynaecology has been a specialty where surgical interventions have been well exposed to the scrutiny of RCTs compared with other surgical specialties.
Introduction
Gynaecology, following the lead of perinatology, is a specialty in which interventions have been exposed to the scrutiny of the randomized controlled trial (RCT) more readily than in many other specialties (Johnson et al., 2003) . Indeed, subfertility was one of the first fields where the need to base practice on evidence from robust randomized trials was highlighted, rather than to conduct a 'cookery based' approach to practice (Vandekerckhove et al., 1993) . Has a similar phenomenon occurred in surgical specialties, including 'gynaecologic surgery from uncertainty to science'? Traditionally in surgical specialties, a non-evidence-based approach to practice has been prevalent. To call this 'butchery based' might be emotive, although no inference should be taken that the surgeons involved were not skilful, but there has been a tendency to adopt the latest surgical technique because it seems rational (or worse, because it demonstrates the technical skill of the surgeon) rather than because it fulfils the stringent criteria for effectiveness that we now demand for non-surgical interventions. Our view, for what it is worth, is that gynaecologists have been less guilty of this phenomenon than other surgical specialists. This is probably linked to the origins of evidence-based practice in the specialty of obstetrics and gynaecology (Johnson et al., 2003) , and our related study reports in detail on the evolution of methodological quality of the randomized trials to which the present study relates (Selman et al., 2008) .
The Cochrane Database of Systematic Reviews provides up-to-date evidence on health care, where bias is minimized. In addition, systematic reviews can also identify 'gaps' where there is insufficient or no evidence, or where the quality of evidence is insufficient. (Johnson et al., 2003) . Elaborate grading systems for evidence exist, although these have largely been designed for formulation of practice guideline recommendations (Guyatt et al. 2006) .
The aim of this study was to assess qualitatively to what extent the Cochrane review groups whose scope covers gynaecologic surgical interventions have been able to provide evidence coverage of this field and where gaps in the evidence remain.
Materials and Methods
The relevant gynaecology review groups (Gynaecological Cancer, Incontinence, Fertility Regulation, Menstrual Disorders and Subfertility Groups) with reviews on the Cochrane Database of Systematic Reviews (Issue 2, 2007) were searched for titles suggesting assessment of a surgical intervention. After confirmation that trials did indeed assess a gynaecologic surgical technique, each review was subgrouped as oncology, urogynaecology, fertility regulation, menstrual disorders, subfertility or other benign gynaecologic surgery.
We had defined a priori a hierarchy of primary outcomes by consensus among the authors of this paper, to be extracted from each systematic review (Selman et al., 2008) , based on what we considered to be outcomes of relevance to patients, as follows.
(i) For oncology reviews: disease eradication;
(ii) For incontinence reviews: subjective 'cure' or dryness (objective 'cure' if not available) in reviews of incontinence; for prolapse reviews: subjective 'cure' or prevention of recurrent prolapse (objective if not available); (iii) For fertility regulation reviews: uncomplicated termination of pregnancy or attainment of sterilization; (iv) For menstrual disorders reviews: subjective 'cure' of heavy menstrual bleeding (HMB) or satisfaction with treatment (objective reduction of HMB if not available); (v) For subfertility reviews: live birth (or clinical pregnancy if data on live birth were not available); (vi) For benign gynaecologic surgery, reviews were assessed and a primary outcome allocated a priori as follows:
(1) return to normal activities (in the absence of extensive quality of life data) for hysterectomy; (2) live birth (or pregnancy) or pain (or recurrent adhesions if not available) for adhesion prevention agents; (3) elimination of ectopic pregnancy; (4) pain for endometriosis surgery (including endometriomas) and neuroablation. If such outcomes were not available, the primary outcomes selected by review authors were considered and a primary outcome agreed upon by consensus among authors of this paper.
The following data were collected for each review: (i) date of the most recent search for trials; (ii) the number of trials and participants contributing to the primary outcomes; (iii) whether there was evidence of a significant difference (whether beneficial or harmful) of the interventions studied for pre-specified primary outcomes from meta-analysis (evidence category allocation 'E' for 'evidence of an effect'), or simply insufficient evidence of effectiveness or harm (evidence category allocation 'G' for 'gap in evidence'). The term 'relative effectiveness' was used when two interventions were compared and the term 'effectiveness' was used when the treatment was compared with either placebo or no treatment. Evidence category 'E&G' was allocated when there was some evidence of significant effects along with some gaps for primary outcomes.
(iv) Methodological difficulties highlighted by the reviewers were also noted.
Results
Thirty completed reviews assessing surgical interventions, from a total of 371 reviews and protocols in gynaecologic oncology, urogynaecology, fertility regulation, menstrual disorders and subfertility, were published on the Cochrane Library. These comprised: (i) two of 84 reviews (n ¼ 47) and protocols (n ¼ 37) from the Gynaecological Cancer Group (Ansink and van der Velden, 2000), only one of which included any RCTs (Martin-Hirsch et al., 2000) ; (ii) six of 69 reviews (n ¼ 51) and protocols (n ¼ 18) from the Incontinence Group Cooper, 2001, 2004; Moehrer et al., 2002; Maher et al., 2004; Bezerra et al., 2005; Lapitan et al., 2005) ; (iii) four of 53 reviews (n ¼ 46) and protocols (n ¼ 7) from the Fertility Regulation Group (Kulier et al. 2001 (Kulier et al. , 2004 Nardin et al. 2003; Say et al., 2005) ; (iv) eighteen of 165 reviews (n ¼ 113) and protocols (n ¼ 52) from the Menstrual Disorders and Subfertility Group, including three menstrual disorders surgery reviews (Lethaby et al., 2000 Marjoribanks et al., 2006) , six subfertility surgery reviews (Johnson and Watson, 1999; Jacobson et al., 2002; Johnson et al., 2004; Farquhar et al., 2005; Ahmad et al., 2006; Van Peperstraten et al., 2006) and nine otherwise uncategorized reviews of benign gynaecologic surgery Jacobson et al., 2001; Hart et al., 2005; Medeiros et al., 2005; Proctor et al., 2005; Johnson et al., 2006; Lethaby et al., 2006; Metwally et al., 2006; Hajenius et al., 2007) The findings of these reviews of gynaecologic surgery and our extracted conclusions are summarized in Tables I -VI. Overall, from the 30 gynaecologic surgery reviews, there was evidence of effectiveness (or relative effectiveness) of the interventions from primary trial data or from meta-analysis of trial data for our a priori defined primary outcomes in seven reviews where clear answers to the clinical questions posed were found (evidence category E) and in a further 11 reviews where evidence of effectiveness for some comparisons or outcomes were found in conjunction with some comparisons or outcomes for which there was insufficient evidence (evidence category E&G). There was insufficient evidence (or a 'gap' in evidence) of effectiveness in 12 reviews (evidence category G). Table VII shows a practical categorization for the various interventions assessed in the 30 gynaecologic surgery reviews. On the basis of this system, 19 recommendations would be that the interventions are likely to show benefit, with 21 recommendations that interventions are likely to be harmful or ineffective (with some duplication from the previous 19 recommendations in the case of interventions whose relative efficacy was found to be inferior to another intervention) and only 13 interventions where the interventions are of unknown benefit.
Evidence-based practice in gynaecologic surgery Discussion Systematic reviews of gynaecologic surgical interventions are under-represented in Cochrane review groups whose scope covers the breadth of gynaecology. This probably reflects the methodological difficulties with conducting randomized trials of surgical interventions. The surprisingly small number of surgical RCTs was most striking in gynaecologic cancer treatment, in which a strong evidence base for techniques of surgical removal of cancer might be expected. This may be due in part to a reluctance of patients with cancer to submit to randomization, difficulties with obtaining ethical approval where a patient with cancer could be randomized to not having the cancer surgically removed, and a discomfort among gynaecologic oncology surgeons to admit to being in equipoise. We have disproved the widely held belief that a clear answer to a clinical dilemma is seldom the case from RCTs or meta-analysis of RCT results, in our finding that a reasonable proportion (60%) of all Cochrane reviews of gynaecologic surgical interventions were able to find evidence of effectiveness or superior relative effectiveness of these interventions for at least some primary outcomes-this figure was 32% for a similar analysis in Cochrane subfertility reviews in 2003 (Johnson et al., 2003) . Some RCTs assessing surgical interventions will have been excluded from this study because they have not yet been included in Cochrane reviews, but such evidence may remain difficult for the average clinician to reach (as there is currently much more relevant literature than an individual clinician can reasonably expect to absorb).
The approach we have used to summarize the level of evidence provided for an intervention (Table VII) can be utilized for guiding practice in gynaecologic surgery. For strong evidence, where the benefits clearly outweigh the risks, patients will commonly make the same choices and surgeons can recommend the intervention with confidence. For weak evidence, patient choice will differ and here surgeons must communicate the evidence with a particular emphasis on patients' individual needs. An example of one such recently published guideline is for laparoscopic uterosacral nerve ablation for the treatment of chronic pelvic pain (http://guidance.nice.org.uk/IPG234). However, our objective was to evaluate the evidence rather than to generate guidelines, this doubtless being the role of authoritative bodies, such as specialty colleges and departments of health.
Pitfalls with systematic reviews have been highlighted (Farquar and Vail, 2006) . In common with trials and systematic reviews of medical interventions, clinical trials and systematic reviews of RCTs in gynaecologic surgery are prone to difficulties with study quality, funding bias, publication bias, reliance on outcomes of little help in clinical decision-making, analysis errors and incorrect use of evidence statements in conclusions. However, surgical trials and systematic reviews have their own unique pitfalls, including a lower threshold for limitations to completion of trials, more limitations to broad applicability of trial results, surgical reputation conflict of interest, in addition to design problems, such as the performance bias resulting from inability to employ blinding (especially concerning subjective outcomes).
There are undoubtedly more confounding variables in surgical RCTs than in the more straightforward A versus B comparison that RCTs address in assessing the effectiveness of medical interventions, including variation in expertise of surgeons with different operations leading to an almost unavoidable confounding surgeon effect. For example, in the largest RCT of laparoscopic versus abdominal or vaginal hysterectomy (Garry et al., 2004) , surgeons were required to have performed only 20 laparoscopic hysterectomies prior to participation in the trial; a similar problem occurred in the first RCT comparing laparoscopic versus open colposuspension (Burton, 1999) , where there was a requirement for surgeons to have performed only 15 laparoscopic colposuspensions (an operation requiring the highest level of laparoscopic surgical expertise) prior to participation, although they would probably have vast experience of the more traditional open surgical approach. It is recognized that the learning curve for these complex laparoscopic surgical procedures may be exceptionally long, where the 'first couple of hundred' advanced laparoscopic procedures appear to be more hazardous than 'the next thousand' cases in any surgeon's series (Johnson, 2006) . Conversely, surgeons participating in trials may be enthusiasts or innovators, so they may not be representative of all surgeons. Major adverse events in surgery are fortunately rare, but RCTs are therefore not often large enough to detect rare adverse events. For example, the ureteric injury rate in the systematic review of RCTs of women randomized to laparoscopic hysteterctomy was 1 in 88, compared with 1 in 512 women randomized to abdominal hysterectomy, but this difference fell short of statistical significance . For Tables I-VI , figures in brackets refer to individual comparisons. Category E, 'Evidence' of effectiveness from meta-analysis; Category G, insufficient evidence (or 'gap' in the evidence); Category E&G, combination of evidence of effectiveness for one primary outcome and a gap in the evidence for another primary outcome; E, 'Evidence' of effectiveness from RCTs; G, 'Gap' in evidence from RCTs; LLETZ, large loop excision of the transformation zone; RCT, randomised controlled trial.
These difficulties with surgical RCTs have led some to suggest that RCTs have little or no place in the evaluation of surgical interventions (Black, 1999) , implying that factors other than RCT evidence, particularly training and expertise among surgeons, patient preferences or even cost of treatments, are more important in determining surgical approach. It would, however, in our opinion, present some danger to introduce new surgical procedures without RCT scrutiny of these new operations versus the current gold standard treatments, as the RCT is the most reliable indicator of the effectiveness of an intervention, whether medical or surgical. Of course, RCT evidence must be integrated with individual surgical expertise in evidence-based surgical practice. The other types of study design (such as case series, even with very large numbers, cohort studies or case-controlled studies), so often relied upon to assess surgical interventions, are prone to unacceptable bias.
A number of prerequisites for surgical RCTs will vastly improve the evidence base in the future. First, pragmatic trials with non-restrictive entry criteria will improve recruitment and generalizability of trial results. Second, only when we collaborate in large multi-centre RCTs of gynaecologic surgical interventions will we have sufficient Evidence-based practice in gynaecologic surgery Surgery, especially hysterectomy, is more effective than medical treatments at reducing menstrual loss at 1 year, but there are no significant differences in quality of life improvement between surgery and the levonorgestrel intrauterine system (E&G) Laparoscopic surgery significantly improves the odds live birth plus ongoing pregnancy (E) Surgical treatment for tubal disease in women due to undergo IVF (Johnson et al., 2004) 3 295 July 2004 Laparoscopic salpingectomy for hydrosalpinges prior to IVF significantly improves the odds of pregnancy and live birth (E) Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome 6 313 July 2005 No significant difference in pregnancy rates between laparoscopic ovarian drilling (6-12 months follow-up) and gonadotrophin injections (3-6 cycles); significantly fewer multiple pregnancies with ovarian drilling (G) Postoperative procedures for improving fertility following pelvic reproductive surgery (Johnson and Watson, 1999) power to find modest improvements that may add up to clinically meaningful improved quality of life, more babies born to infertile couples or even lives saved. Such an approach enhances generalizability and speeds recruitment, thus avoiding the problem seen with laparoscopic colposuspension, an operative intervention that became Excisional surgery is superior for avoiding recurrence of pelvic pain and endometriomata, and improving fertility (E) Barrier agents for preventing adhesions after surgery for subfertility 15 959 April 1999 Although there is a significant reduction in pelvic adhesion formation, there is no evidence of a significant difference in odds of pregnancy for Interceed versus no treatment at laparoscopy (both reformation and de-novo)
Interceed versus no treatment at laparotomy Gore-Tex versus no treatment Seprafilm versus no treatment for myomectomy Gore-Tex versus Interceed (G) Fluid and pharmacological agents for adhesion prevention after gynaecological surgery (Metwally et al., 2006) Evidence-based practice in gynaecologic surgery almost obsolete before the evidence base was established, owing to the rapid progress that is typical of most surgical fields. A third key is the pursuit of important long-term outcomes, which are rarely reported in surgical RCTs. For example, no long-term outcomes were reported in 23 RCTs of surgical approach to hysterectomy , including satisfaction, quality of life or longterm urinary, bowel or fistula complications. A further difficulty is the masking of long-term outcomes in the pursuit of less relevant surrogate outcomes-the many RCTs on adhesion prevention usually include a second look laparoscopy to assess adhesions, often combining this with adhesiolysis, thereby confounding the true primary outcomes of interest, either subsequent pregnancy outcome or pain outcomes . Fourth, recognition and acknowledgement of the limitations of evidencebased surgery by its proponents will go a long way to ensuring it is embraced by the majority of thoughtful practicing gynaecologic surgeons.
In conclusion, gynaecologic surgery has moved from a nonscientific to an evidence-based approach, but gaps in the evidence supporting gynaecologic surgical interventions have been highlighted. Notwithstanding the difficulties with methodology and conduct of RCTs of surgical interventions, we Interventions of unknown benefit Anterior vaginal repair versus physical therapy, suburethral sling operations, laparoscopic colposuspension and alternative vaginal operations Bladder neck needle suspension versus conservative management, perurethral injections, sham surgery and laparoscopic surgery Open retropubic colposuspension versus suburethral sling and laparoscopic colposuspension Suburethral slings versus laparoscopic retropubic suspension, anterior repair, per-urethral injections and artificial sphincters Prolapse surgery on continence issues Infertility surgery versus no treatment or alternative treatment Use of magnification in tubal surgery Any particular technique for surgical retrieval of sperm Long-term outcomes of different surgical approach to hysterectomy for benign gynaecological disease Expectant management for the treatment of tubal ectopic pregnancy Significant difference in the odds of pregnancy for barrier agents for preventing adhesions after surgery for subfertility Fluid and pharmacological agents for adhesion prevention after gynaecological surgery Significant additional effect of LUNA in laparoscopic removal of endometriosis need to organize well-powered multi-centre trials of surgical interventions-in doing so, we will move completely away from a non-scientific to a scientific basis for surgery.
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